March 23, 2017 03:53 PM EDT

Sleuthy Google upstart Calico forges a rare biotech collaboration on aging with Novartis-backed C4

John Carroll

Editor & Founder

The elusive but widely buzzed about Calico, a startup bankrolled by Google to find new therapies for aging, has hitched up with protein degeneration-focused C4 …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Sleuthy Google upstart Calico forges a rare biotech collaboration on aging with Novartis-backed C4

John Carroll

Editor & Founder

Sign up to read this article for free.

Sr. Manager/Associate Director, Document Control

Viridian Therapeutics

Waltham, MA, USA

BridgeBio shares promising results in trial of Canavan disease gene therapy

CRISPR therapy reduces swelling attacks by 81% in Intellia follow-up study

Facing lost rebates, MGM Resorts to stop covering GLP-1 weight loss shots

Exclusive: University of Toronto spinout raises $53.5M to create new obesity drugs with AI

Icon's quarterly earnings hit by biotech and pharma pullback

IDEAYA Biosciences: Targeting unmet market needs with precision oncology

Sleuthy Google up­start Cal­i­co forges a rare biotech col­lab­o­ra­tion on ag­ing with No­var­tis-backed C4

Editor & Founder

Sign up to read this article for free.

Viridian Therapeutics

Waltham, MA, USA

Sleuthy Google upstart Calico forges a rare biotech collaboration on aging with Novartis-backed C4